Skip to content

EyePoint, Inc. EYPT Royalty Purchase Agreement — Upfront Cash Payment

Other product segments

Product Rights Agreement
$75M0.0%

Similar metrics at other companies

Ionis Pharmaceuticals logo
IONSUpfront Royalty Payment Received
$500M
Opko Health logo
OPKTransfer Of Intellectual Property And Other — Upfront Payment
$1.75M
Ligand Pharmaceuticals logo
LGNDPayments To Acquire Financial Royalty Assets
$0-100%
Enovis logo
ENOVPurchase of royalty interest
$0-100%
Mannkind logo
MNKDProceeds From Sale Of Future Royalties
$37.5M
uniQure logo
QUREProceeds From Royalty Financing Agreement Net Of Issuance Costs
$92.52M

Other financials

Income statement

See full
Revenue$696.0K-97.2%
Gross profit$9.8M-30.1%
Operating income-$87.2M-78.6%
Net income-$84.8M-87.7%
EPS (diluted)-$0.99-52.3%

Balance sheet

See full
Cash & equivalents$77.7M-8.7%
Total debt$22.3M-7.3%
Total equity$230.5M-22.8%
Total assets$288.2M-20.5%

Cash flow

See full
Operating cash flow-$80.5M-51.6%
CapEx$997.0K+261%
Free cash flow-$81.5M-52.7%

Valuation

See full
Market cap$1.21B+189%
Enterprise value$1.15B+228%
P/S158.5×+151×

Profitability

See full
Operating margin-3,700.9%-4,042pp
Net margin-3,566.6%-3,874pp
FCF margin-3,565.9%-3,884pp

Returns & leverage

See full
Return on equity-102.7%+1,157pp
Debt / equity0.1×0.0×
Current ratio6.7×-1.2×

Where this comes from

Reported directly by EyePoint, Inc. in its filing.

Tagged under the XBRL concept eypt:UpfrontCashPayment.

The official record: EyePoint, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about EyePoint, Inc. 's royalty purchase agreement — upfront cash payment.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EyePoint, Inc. 's royalty purchase agreement — upfront cash payment?
EyePoint, Inc. (EYPT) reported royalty purchase agreement — upfront cash payment of $16.5M in Q1 2026.
What does royalty purchase agreement — upfront cash payment mean?
Represents the initial lump-sum cash consideration received by the company upon the execution of a royalty purchase agreement. This payment serves as immediate capital inflow in exchange for the future assignment of royalty rights to a third party. It reflects the upfront monetization of long-term intellectual property assets.